Showing results (141-150 of 228) with videos related to

Sort By:
Pageof 23
The Journal of Urology|October 20, 2009
Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomyYakup Kordan, Shady Salem, Sam S Chang, et al.
The Journal of Urology|January 20, 2010
Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survivalDaniel A Barocas, Shady Salem, Yakup Kordan, et al.
Urologic Oncology|January 22, 2017
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinomaZachary A Glaser, Harold D Love, Shunhua Guo, et al.
The Journal of Urology|October 26, 2018
Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled TrialChad R Ritch, Michael S Cookson, Peter E Clark, et al.
Clinical Genitourinary Cancer|April 16, 2023
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate CancerDaniel J George, Fred Saad, Michael S Cookson, et al.
The Journal of Urology|September 18, 2009
Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomyYakup Kordan, Sam S Chang, Shady Salem, et al.
The Journal of Urology|November 16, 2010
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancerJustin R Gregg, Michael S Cookson, Sharon Phillips, et al.
European Urology|January 15, 2013
Screening for bladder cancer: rationale, limitations, whom to target, and perspectivesStéphane Larré, James W F Catto, Michael S Cookson, et al.
European Urology Oncology|December 24, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO StudyRonald Tutrone, Fred Saad, Daniel J George, et al.
Urology|April 22, 2014
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancerChad R Ritch, Chaochen You, Alexandra T May, et al.
Pageof 23